OBR Daily Commentary

forumImage

Consumer Blood Test to Detect Cancer Hits Market Amid Skepticism

(Bloomberg) Sept 10, 2015 - Biotechnology startup Pathway Genomics Corp. is introducing the first "liquid biopsy" tests designed to detect cancer-associated mutations in the blood of healthy people who are at high risk of developing tumors.

Read Article arrow

Dean Gesme, MD (Posted: September 10, 2015)

quotesWhile fascinating on the surface, the clinical and moral implications for clinicians, patients and payers will be stretched thin when circulating tumor cells cannot otherwise be associated with a primary site of malignancy. This has already created unresolved dilemmas in maternal/fetal medicine when cancer-specific mutations are unexpectedly discovered when testing for other genetic defects.quotes

Add Comment 1 Comment
forumImage

NantHealth and IOBS Announce Successful Results of Improved Patient Care with Reduced Costs from Community Oncology Medical Home (COME HOME) Program

(Yahoo! Finance) Sept 9, 2015 - NantHealth Operating System (NantOS) enabled sharing of clinical information across the United States from multiple different electronic health records and practice management systems; Journal of Oncology publishes study results for Innovative Oncology Business Solution’s (IOBS) successful COME HOME Program.

Read Article arrow

Dean Gesme, MD (Posted: September 09, 2015)

quotesClinical and financial data capture and analysis is now the Holy Grail but will soon be the minimum requirement to practice oncology in this Brave New World.quotes

Add Comment 1 Comment
forumImage

Op-Ed: Should We Charge Patients for Medical Research?

(New York Times) July 31, 2015 - A few months ago, we got a call from a former oncology professor of ours.

Read Article arrow

Dean Gesme, MD (Posted: August 03, 2015)

quotesA very slippery ethical slope if "pay to play" clinical research entrepreneurial enterprises were to resurface -- as discussed in this NY Times guest editorial.quotes

Add Comment 1 Comment

Meet the Editorial Board

Prostate Cancer
member photo
Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical O...

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Ca...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Woo...

Radiation Oncology
member photo
Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Pr...

Community Oncology
member photo
Jeff Patton, M.D.

CEO Tennessee Oncology...

Precision Medicine Section Editor
member photo
Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One...

Financial Sector
member photo
Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst...

Gastrointestinal Cancers
member photo
Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signa...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Community Oncology
member photo
William Harwin MD

Florida Cancer Specialists President and Managing Part...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...

Payer
member photo
Winston Wong, PharmD

President, W-Squared Group...